CARPB - Overview: Carbamazepine Hypersensitivity Pharmacogenomics, Blood

Test Catalog

Test Name

Test ID: CARPB    
Carbamazepine Hypersensitivity Pharmacogenomics, Blood

Useful For Suggests clinical disorders or settings where the test may be helpful

Identifying individuals with increased risk of risk of carbamazepine-associated cutaneous adverse reactions


Identifying individuals who may be at increased risk of cutaneous adverse reactions when treated with alternative medications to carbamazepine including phenytoin, fosphenytoin, oxcarbazepine, eslicarbazepine acetate, and lamotrigine

Genetics Test Information Provides information that may help with selection of the correct genetic test or proper submission of the test request

Detection of the HLA-B*15:02 allele (HLA00165) in the HLA-B gene (NM_005514).


Detection of the HLA-A*31:01 allele (HLA00097) in the HLA-A gene (NM_001242758).

Special Instructions and Forms Library of PDFs including pertinent information and consent forms, specimen collection and preparation information, test algorithms, and other information pertinent to test

Method Name A short description of the method used to perform the test

Qualitative Allele-Specific Real-Time Polymerase Chain Reaction (PCR)

NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.


Reporting Name A shorter or abbreviated version of the Published Name for a test; an abbreviated test name

Carbamazepine PGx Panel, B

Aliases Lists additional common names for a test, as an aid in searching

HLAA 3101
Carbamazepine Hypersensitivity
Fosphenytoin Hypersensitivity
Oxcarbazepine Hypersensitivity
Phenytoin Hypersensitivity
Lamotrigine Hypersensitivity
Stevens-Johnson Syndrome, Carbamazepine, Oxcarbazepine, Phenytoin, Fosphenytoin, or Lamotrigine
Toxic Epidermal Necrosis (TEN), Carbamazepine, Oxcarbazepine, Phenytoin, Fosphenytoin, or Lamotrigine.